News All the latest news and information about the care, research, teaching and management we do at Vall d’Hebron Barcelona Hospital Campus. Don't miss any details! Fulltext search Search New study shows that COVID-19 can damage the placenta of pregnant women 05/10/2021 IMIDomics, a Vall d'Hebron spin-off, raises $16.5 million to develop new drugs against immunomediated inflammatory diseases 27/07/2021 Endolipid Therapeutics, the spin-off of Vall d’Hebron and GENESIS Ventures, emerges to develop a new strategy to reduce visceral and subcutaneous fat 16/06/2021 Vall d’Hebron identifies memory immune cells in blood and lungs essential for the control of SARS-CoV-2 20/05/2021 Great participation of professionals from Vall d'Hebron in the 2nd National Congress of COVID-19 12/04/2021 Vall d'Hebron identifies a key protein to prevent breast cancer metastases 08/09/2020 A new European project awarded to the CIBBIM-Nanomedicine of the VHIR converts the Vall d'Hebron Campus into the health institution with the most active research projects in Nanomedicine of Europe 25/04/2018 Campus Vall d'Hebron signs a Prime Site Agreement with IQVIA, the world's largest clinical trial management company 23/04/2018 Vall d'Hebron Campus receives the visit of a delegation from the Cluster of Clinical Excellence of the Chamber of Commerce of Cali 26/03/2018 Pagination « First First page ‹ Previous Previous page 1 2